Floatz logo

Epirubicin

MSS

University Hospital HeidelbergPhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the MSS cohort.

Asset / SponsorPhaseRating
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
FLUOROURACILUM
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B
Cetuximab
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3B

View all 29 →

Same molecule, other indications

Epirubicin is also rated in:

Recurrent Breast CarcinomaDormant
BBB
Indicative ·
74 / 100
View asset →
Lung Non-Small Cell Squamous CarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →